Tumor budding in colorectal cancer revisited: results of a multicenter interobserver study

Virchows Archiv

Volumn 466, Issue 5, 2015, Pages 485-493

  Koelzer, Viktor H ^a   Zlobec, Inti ^a   Berger, Martin D ^b   Cathomas, Gieri ^c   Dawson, Heather ^a   Dirschmid, Klaus ^d   Hädrich, Marion ^b   Inderbitzin, Daniel ^b,e   Offner, Felix ^d   Puppa, Giacomo ^f   Seelentag, Walter ^g   Schnüriger, Beat ^b   Tornillo, Luigi ^h   Lugli, Alessandro ^a  

^a UNIVERSITY OF BERN   (Switzerland)

^b UNIVERSITY OF BERN   (Switzerland)

^c Psychiatrie Baselland   (Switzerland)

^d Academic Teaching Hospital Feldkirch   (Austria)

^e Spital Bern Tiefenau   (Switzerland)

^f GENEVA UNIVERSITY HOSPITALS   (Switzerland)

^g Institut de Pathologie Romand (IPR)   (Switzerland)

^h UNIVERSITY HOSPITAL BASEL   (Switzerland)

Author keywords

Colorectal cancer; Interobserver; Lymph node metastasis; Prognostic factor; TNM stage; Tumor budding

Indexed keywords

AGED; CLINICAL TRIAL; COLORECTAL TUMOR; COMPUTER ASSISTED DIAGNOSIS; FEMALE; HUMAN; MALE; MIDDLE AGED; MULTICENTER STUDY; OBSERVER VARIATION; PATHOLOGY;

AGED; COLORECTAL NEOPLASMS; FEMALE; HUMANS; IMAGE INTERPRETATION, COMPUTER-ASSISTED; MALE; MIDDLE AGED; OBSERVER VARIATION;

EID: 84937511817     PISSN: 09456317     EISSN: 14322307     Source Type: Journal    
DOI: 10.1007/s00428-015-1740-9     Document Type: Article

References (29)

1. Choi DH, Sohn DK, Chang HJ, Lim SB, Choi HS, Jeong SY (2009) Indications for subsequent surgery after endoscopic resection of submucosally invasive colorectal carcinomas: a prospective cohort study. Dis Colon Rectum 52:438–445. doi:10.1007/DCR.0b013e318197e37f
2. Compton C (2014) Pathology and prognostic determinants of colorectal cancer. In: UpToDate, Basow, DS (Ed), UpToDate, Waltham, MA, USA
3. Dirnhofer S, Bubendorf L, Lehr H-A, Landau B, Zenklusen HR (2011) SGPath Quality Guidelines. 1st ed. Rheinfelden, Switzerland: lebensart003:78–80
4. Giger OT, Comtesse SC, Lugli A, Zlobec I, Kurrer MO (2012) Intra-tumoral budding in preoperative biopsy specimens predicts lymph node and distant metastasis in patients with colorectal cancer. Modern Pathol: Off J U S Can Acad Pathol, Inc 25:1048–1053. doi:10.1038/modpathol.2012.56
5. Gospodarowicz MK, O’Sullivan B, Sobin LH (2006) Prognostic factors in cancer, 3rd edn. Wiley, New York, pp 267–279
6. Hase K, Shatney C, Johnson D, Trollope M, Vierra M (1993) Prognostic value of tumor “budding” in patients with colorectal cancer. Dis Colon Rectum 36:627–635
7. Horcic M, Koelzer VH, Karamitopoulou E, Terracciano L, Puppa G, Zlobec I, Lugli A (2013) Tumor budding score based on 10 high-power fields is a promising basis for a standardized prognostic scoring system in stage II colorectal cancer. Hum Pathol 44:697–705. doi:10.1016/j.humpath.2012.07.026
8. Karamitopoulou E, Zlobec I, Kolzer V, Kondi-Pafiti A, Patsouris ES, Gennatas K, Lugli A (2013) Proposal for a 10-high-power-fields scoring method for the assessment of tumor budding in colorectal cancer. Modern Pathol: Off J U S Can Acad Pathol, Inc 26:295–301. doi:10.1038/modpathol.2012.155
9. Kevans D, Wang LM, Sheahan K, Hyland J, O’Donoghue D, Mulcahy H, O’Sullivan J (2011) Epithelial-mesenchymal transition (EMT) protein expression in a cohort of stage II colorectal cancer patients with characterized tumor budding and mismatch repair protein status. Int J Surg Pathol 19:751–760. doi:10.1177/1066896911414566
10. Koelzer VH, Zlobec I, Lugli A (2014) Tumor budding in the clinical management of colon and rectal cancer. Colorectal Cancer 3:387–403. doi:10.2217/crc.14.21
11. Lugli A, Karamitopoulou E, Zlobec I (2012) Tumour budding: a promising parameter in colorectal cancer. Br J Cancer 106:1713–1717. doi:10.1038/bjc.2012.127
12. Lugli A, Vlajnic T, Giger O, Karamitopoulou E, Patsouris ES, Peros G, Terracciano LM, Zlobec I (2011) Intratumoral budding as a potential parameter of tumor progression in mismatch repair-proficient and mismatch repair-deficient colorectal cancer patients. Hum Pathol 42:1833–1840. doi:10.1016/j.humpath.2011.02.010
13. Mitrovic B, Schaeffer DF, Riddell RH, Kirsch R (2012) Tumor budding in colorectal carcinoma: time to take notice. Modern Pathol: Off J U S Can Acad Pathol, Inc 25:1315–1325. doi:10.1038/modpathol.2012.94
14. Morodomi T, Isomoto H, Shirouzu K, Kakegawa K, Irie K, Morimatsu M (1989) An index for estimating the probability of lymph node metastasis in rectal cancers. Lymph node metastasis and the histopathology of actively invasive regions of cancer. Cancer 63:539–543
15. Nakadoi K, Tanaka S, Kanao H, Terasaki M, Takata S, Oka S, Yoshida S, Arihiro K, Chayama K (2012) Management of T1 colorectal carcinoma with special reference to criteria for curative endoscopic resection. J Gastroenterol Hepatol 27:1057–1062. doi:10.1111/j.1440-1746.2011.07041.x
16. Nakamura T, Mitomi H, Kikuchi S, Ohtani Y, Sato K (2005) Evaluation of the usefulness of tumor budding on the prediction of metastasis to the lung and liver after curative excision of colorectal cancer. Hepato-Gastroenterology 52:1432–1435
17. Ohtsuki K, Koyama F, Tamura T, Enomoto Y, Fujii H, Mukogawa T, Nakagawa T, Uchimoto K, Nakamura S, Nonomura A, Nakajima Y (2008) Prognostic value of immunohistochemical analysis of tumor budding in colorectal carcinoma. Anticancer Res 28:1831–1836
18. Okuyama T, Oya M, Ishikawa H (2002) Budding as a risk factor for lymph node metastasis in pT1 or pT2 well-differentiated colorectal adenocarcinoma. Dis Colon Rectum 45:628–634
19. Prall F, Nizze H, Barten M (2005) Tumour budding as prognostic factor in stage I/II colorectal carcinoma. Histopathology 47:17–24. doi:10.1111/j.1365-2559.2005.02161.x
20. Puppa G, Senore C, Sheahan K, Vieth M, Lugli A, Zlobec I, Pecori S, Wang LM, Langner C, Mitomi H, Nakamura T, Watanabe M, Ueno H, Chasle J, Conley SA, Herlin P, Lauwers GY, Risio M (2012) Diagnostic reproducibility of tumour budding in colorectal cancer: a multicentre, multinational study using virtual microscopy. Histopathology 61:562–575. doi:10.1111/j.1365-2559.2012.04270.x
21. Rogers AC, Gibbons D, Hanly AM, Hyland JM, O’Connell PR, Winter DC, Sheahan K (2013) Prognostic significance of tumor budding in rectal cancer biopsies before neoadjuvant therapy. Modern Pathol: Off J U S Can Acad Pathol, Inc. doi:10.1038/modpathol.2013.124
22. Shinto E, Jass JR, Tsuda H, Sato T, Ueno H, Hase K, Mochizuki H, Matsubara O (2006) Differential prognostic significance of morphologic invasive markers in colorectal cancer: tumor budding and cytoplasmic podia. Dis Colon Rectum 49:1422–1430. doi:10.1007/s10350-006-0595-1
23. Sobin LH, Gospodarowicz MK, Wittekind C, International Union against Cancer (2010) TNM classification of malignant tumours. Wiley-Blackwell, Chichester
24. Tateishi Y, Nakanishi Y, Taniguchi H, Shimoda T, Umemura S (2010) Pathological prognostic factors predicting lymph node metastasis in submucosal invasive (T1) colorectal carcinoma. Modern Pathol: Off J U S Can Acad Pathol, Inc 23:1068–1072. doi:10.1038/modpathol.2010.88
25. Ueno H, Murphy J, Jass JR, Mochizuki H, Talbot IC (2002) Tumour ‘budding’ as an index to estimate the potential of aggressiveness in rectal cancer. Histopathology 40:127–132
26. Wang HS, Liang WY, Lin TC, Chen WS, Jiang JK, Yang SH, Chang SC, Lin JK (2005) Curative resection of T1 colorectal carcinoma: risk of lymph node metastasis and long-term prognosis. Dis Colon Rectum 48:1182–1192. doi:10.1007/s10350-004-0935-y
27. Wang LM, Kevans D, Mulcahy H, O’Sullivan J, Fennelly D, Hyland J, O’Donoghue D, Sheahan K (2009) Tumor budding is a strong and reproducible prognostic marker in T3N0 colorectal cancer. Am J Surg Pathol 33:134–141. doi:10.1097/PAS.0b013e318184cd55
28. Yamauchi H, Togashi K, Kawamura YJ, Horie H, Sasaki J, Tsujinaka S, Yasuda Y, Konishi F (2008) Pathological predictors for lymph node metastasis in T1 colorectal cancer. Surg Today 38:905–910. doi:10.1007/s00595-007-3751-x
29. Zlobec I, Hadrich M, Dawson H, Koelzer VH, Borner M, Mallaev M, Schnuriger B, Inderbitzin D, Lugli A (2013) Intratumoural budding (ITB) in preoperative biopsies predicts the presence of lymph node and distant metastases in colon and rectal cancer patients. Br J Cancer. doi:10.1038/bjc.2013.797